Skip to content

Clinical trials

Cardiovascular Diseases trials in China with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Not applicable Country / region: China Clear all

100 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20061
20082
20092
20102
20112
20123
20131
20142
20153
20164
20173
20186
20194
20205
20216
202210
202311
202412
202512
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Unknown status24
Recruiting19
Not yet recruiting10
Active, not recruiting5
Enrolling by invitation4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Nanjing Medical University5
Medtronic Vascular4
China National Center for Cardiovascular Diseases3
Huazhong University of Science and Technology3
Nanfang Hospital, Southern Medical University3
Peking University3
The First Affiliated Hospital with Nanjing Medical University3
The George Institute for Global Health, China3
AstraZeneca2
Beijing Tiantan Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases100
Hypertension14
Coronary Artery Disease13
Vascular Diseases12
Myocardial Ischemia11
Cerebrovascular Disorders10
Stroke10
Diabetes Mellitus, Type 28
Arteriosclerosis7
Brain Diseases7

Trials

Showing 1 to 25 of 100. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.